Eupraxia Pharmaceuticals Inc. (TSX: EPRX)
Canada
· Delayed Price · Currency is CAD
4.740
-0.290 (-5.77%)
Nov 21, 2024, 2:40 PM EST
Eupraxia Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Cash & Equivalents | 8.66 | 19.34 | 18.26 | 20.89 | 0.15 | 1.16 | Upgrade
|
Short-Term Investments | - | - | - | 9.01 | - | - | Upgrade
|
Cash & Short-Term Investments | 8.66 | 19.34 | 18.26 | 29.9 | 0.15 | 1.16 | Upgrade
|
Cash Growth | -64.72% | 5.90% | -38.92% | 19817.22% | -87.01% | 40.39% | Upgrade
|
Other Receivables | 0.11 | 0.19 | 0.09 | 0.43 | 0.62 | 1.35 | Upgrade
|
Receivables | 0.11 | 0.19 | 0.09 | 0.43 | 0.62 | 1.35 | Upgrade
|
Prepaid Expenses | 1.12 | 0.27 | 0.24 | 0.27 | 0.37 | 0.13 | Upgrade
|
Total Current Assets | 9.89 | 19.8 | 18.59 | 30.6 | 1.14 | 2.64 | Upgrade
|
Property, Plant & Equipment | 0.46 | 0.46 | 0.53 | 0.59 | 0.32 | 0.65 | Upgrade
|
Other Long-Term Assets | 0.02 | 0.01 | 0 | 0.03 | - | - | Upgrade
|
Total Assets | 10.36 | 20.27 | 19.12 | 31.22 | 1.45 | 3.29 | Upgrade
|
Accrued Expenses | 2.27 | 3.87 | 2.91 | 2.11 | 3.04 | 2.18 | Upgrade
|
Short-Term Debt | - | - | - | - | 12.52 | 11.63 | Upgrade
|
Current Portion of Long-Term Debt | - | 10.4 | 0.08 | 0.09 | - | - | Upgrade
|
Current Portion of Leases | 0.08 | 0.05 | 0.05 | 0.06 | 0.05 | 0.06 | Upgrade
|
Current Income Taxes Payable | - | 0.04 | - | - | - | - | Upgrade
|
Other Current Liabilities | 0.02 | 5.02 | 0.02 | 0.01 | 6.94 | 6.8 | Upgrade
|
Total Current Liabilities | 2.37 | 19.37 | 3.06 | 2.27 | 22.54 | 20.67 | Upgrade
|
Long-Term Debt | - | - | 8.8 | 9.7 | - | - | Upgrade
|
Long-Term Leases | 0.01 | - | 0.05 | 0.14 | 0.2 | 0.25 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | 0.38 | 0.5 | Upgrade
|
Total Liabilities | 2.39 | 19.37 | 11.91 | 12.1 | 23.12 | 21.42 | Upgrade
|
Common Stock | 116.32 | 92.91 | 71 | 77.65 | 23.8 | 23.55 | Upgrade
|
Additional Paid-In Capital | 19.49 | 17.51 | 16.85 | - | 6.19 | 5.96 | Upgrade
|
Retained Earnings | -123.49 | -105.5 | -77.28 | -74.26 | -51.2 | -47.2 | Upgrade
|
Comprehensive Income & Other | -2.79 | -2.71 | -2.79 | 16.56 | - | - | Upgrade
|
Total Common Equity | 9.52 | 2.22 | 7.79 | 19.95 | -21.21 | -17.69 | Upgrade
|
Minority Interest | -1.54 | -1.32 | -0.58 | -0.83 | -0.45 | -0.44 | Upgrade
|
Shareholders' Equity | 7.98 | 0.89 | 7.21 | 19.12 | -21.66 | -18.13 | Upgrade
|
Total Liabilities & Equity | 10.36 | 20.27 | 19.12 | 31.22 | 1.45 | 3.29 | Upgrade
|
Total Debt | 0.09 | 10.45 | 8.99 | 9.99 | 12.77 | 11.94 | Upgrade
|
Net Cash (Debt) | 8.57 | 8.89 | 9.28 | 19.91 | -12.62 | -10.78 | Upgrade
|
Net Cash Growth | -34.86% | -4.18% | -53.40% | - | - | - | Upgrade
|
Net Cash Per Share | 0.27 | 0.37 | 0.48 | 1.60 | -2.06 | -1.76 | Upgrade
|
Filing Date Shares Outstanding | 35.62 | 35.62 | 27.36 | 14.24 | 12.87 | 6.12 | Upgrade
|
Total Common Shares Outstanding | 35.62 | 27.28 | 21.59 | 14.24 | 6.18 | 6.12 | Upgrade
|
Working Capital | 7.52 | 0.43 | 15.53 | 28.33 | -21.4 | -18.03 | Upgrade
|
Book Value Per Share | 0.27 | 0.08 | 0.36 | 1.40 | -3.43 | -2.89 | Upgrade
|
Tangible Book Value | 9.52 | 2.22 | 7.79 | 19.95 | -21.21 | -17.69 | Upgrade
|
Tangible Book Value Per Share | 0.27 | 0.08 | 0.36 | 1.40 | -3.43 | -2.89 | Upgrade
|
Buildings | - | - | - | 0.09 | 0.08 | 0.1 | Upgrade
|
Machinery | 0.7 | 0.68 | 0.61 | 0.13 | 0.09 | 0.09 | Upgrade
|
Leasehold Improvements | 0.13 | 0.13 | 0.13 | 0.17 | 0.11 | 0.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.